Attorney General Raoul Announces Multistate Agreement With Opioid Manufacturer Hikma Pharmaceuticals
CHICAGO - Attorney General Kwame Raoul, as part of a bipartisan group of attorneys general, today announced a $150 million multistate settlement agreement in principle with opioid manufacturer Hikma Pharmaceuticals (Hikma) for its role in fueling the opioid crisis. Raoul’s office also announced today a $350 million national settlement with Publicis Health to resolve investigations into the global marketing and communications firm’s role in the prescription opioid epidemic. Hikma produces a range of branded and generic opioid products and sells hundreds of millions of opioid doses every year. The agreement in principle resolves claims that from 2006 to 2021, Hikma failed to monitor and report suspicious opioid orders from potentially illegal distributors, even as personnel knew their systems to monitor suspicious orders were inadequate and prone to failure. Once finalized, the settlement will provide up to $115 million in cash and $35 million in opioid addiction treatment
stLouIST